Profile
Dakota Gallivan is Chief Healthcare Compliance Officer & VP at Reata Pharmaceuticals, Inc. Mr. Gallivan previously occupied the position of Compliance Counsel at Pharmacyclics LLC. Mr. Gallivan received an undergraduate degree from St. Francis College and a graduate degree from Seton Hall University School of Law.
Former positions of Dakota Gallivan
| Companies | Position | End |
|---|---|---|
| REATA PHARMACEUTICALS, INC. | Compliance Officer | 26/09/2023 |
| DERMIRA, INC. | General Counsel | 01/01/2020 |
| PHARMACYCLICS, INC. | General Counsel | 01/04/2018 |
| Medivation, Inc. /Old/ | General Counsel | 01/04/2017 |
| PFIZER, INC. | General Counsel | 01/04/2017 |
Training of Dakota Gallivan
| St. Francis College | Undergraduate Degree |
| Seton Hall University School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
| Medivation, Inc. /Old/ | Health Technology |
- Stock Market
- Insiders
- Dakota Gallivan
